Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Zai Lab Gains 5.65% to $19.65 as FDA Grants Second Fast Track Designation to DLL3-Targeting ADC

Zai Lab Limited (NASDAQ: ZLAB) added 5.65 per cent on Tuesday to close at $19.65, lifted by news that the FDA has extended a second Fast Track Designation to zocilurtatug pelitecan — known within the oncology community as zoci — for the treatment of …

Nitish Kishor | 11 May 2026